Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | BACE1 | P56817 | 2/20 | 0.44 |
| ▸ | CTSD | P07339 | 1/20 | 0.44 |
| ▸ | FNTA | P49354 | 1/20 | 0.44 |
| ▸ | FNTB | P49356 | 1/20 | 0.44 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | LAP3 | P28838 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.42 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.41 |
| ▸ | ACE | P12821 | 5/20 | 0.40 |
| ▸ | LARS1 | Q9P2J5 | 1/20 | 0.40 |
| ▸ | MME | P08473 | 1/20 | 0.40 |
| ▸ | CPA1 | P15085 | 1/20 | 0.40 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3303877 | 1.00 | SLC7A5 (0.50) | SLC7A5ALDH1A1BACE1CTSDFNTA | |
| SCHEMBL9551440 | 0.97 | SLC7A5 (0.47) | SLC7A5ALDH1A1BACE1CTSDFNTA | |
| SCHEMBL10621390 | 0.97 | SLC7A5 (0.47) | SLC7A5ALDH1A1BACE1CTSDFNTA | |
| SCHEMBL29591958 | 0.93 | BACE1 (0.47) | SLC7A5BACE1CTSDFNTAFNTB | |
| SCHEMBL30753843 | 0.93 | FNTA (0.47) | SLC7A5ALDH1A1BACE1CTSDFNTA | |
| SCHEMBL30584447 | 0.92 | BACE1 (0.47) | SLC7A5ALDH1A1BACE1CTSDFNTA | |
| Leu-Ala SCHEMBL259115 | 0.91 | SLC7A5 (0.59) | SLC7A5ALDH1A1BACE1CTSDMAPT | |
| Leu-Ala SCHEMBL14117889 | 0.91 | SLC7A5 (0.59) | SLC7A5ALDH1A1BACE1CTSDMAPT | |
| Leu-Ala SCHEMBL2030930 | 0.91 | SLC7A5 (0.59) | SLC7A5ALDH1A1BACE1CTSDMAPT | |
| Leu-Ala SCHEMBL31696288 | 0.91 | SLC7A5 (0.59) | SLC7A5ALDH1A1BACE1CTSDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6910 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250206841-A1 | ANTI-TROPHOBLAST CELL SURFACE ANTIGEN 2 (TROP-2) ANTIBODIES | ADEPT BIOPHARMACEUTICAL AND TECHNOLOGY, LTD. (CN) | 2025-06-26 | — | — | US | claimed |
| CN-119604527-A | Anti-programmed death ligand 1 (PD-L1) antibodies | 安得泰医药有限公司 | 2025-03-11 | — | — | CN | claimed |
| EP-4486783-A2 | ANTI-PROGRAMMED DEATH-LIGAND 1 (PD-L1) ANTIBODIES | Adept Therapeutics Inc. (US) | 2025-01-08 | — | — | EP | claimed |
| EP-4483959-A2 | NOVEL PEPTIDE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | EYEBIO KOREA (KR) | 2025-01-01 | — | — | EP | claimed |
| CN-118702774-A | Preparation method and application of polypeptide coupling compound of targeted GPC-3 protein | 上海大学 | 2024-09-27 | — | — | CN | claimed |
| US-20240228538-A1 | Novel Peptide Compound Or Pharmaceutically Acceptable Salt Thereof | EYEBIO KOREA (KR) | 2024-07-11 | — | — | US | claimed |
| US-20240209054-A1 | GIP AGONIST COMPOUNDS AND METHODS | ZEALAND PHARMA A/S (DK) | 2024-06-27 | — | — | US | claimed |
| CN-117736269-A | Polypeptide-photosensitizer targeting GPC-3 as well as preparation method and application thereof | 中国人民解放军海军军医大学 | 2024-03-22 | — | — | CN | claimed |
| WO-2024059686-A2 | DARPIN BACKBONES AND RIGIDIFIED ELECTRON MICROSCOPY IMAGING SCAFFOLDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-03-21 | — | — | WO | claimed |
| US-20240059753-A1 | COMPOSITIONS INCLUDING MULTI-AGONIST PEPTIDES AND METHODS OF MANUFACTURE AND USE | PEP2TANGO THERAPEUTICS INC. | 2024-02-22 | — | — | US | claimed |
| EP-4146248-A1 | LONG ACTING GLP-1/GIP DUAL AGONISTS | Sun Pharmaceutical Industries Limited (IN) | 2023-03-15 | — | — | EP | claimed |
| CN-115768460-A | Long-acting GLP-1/GIP dual agonists | 太阳医药工业有限公司 | 2023-03-07 | — | — | CN | claimed |
| EP-4126920-A2 | GIF RECEPTOR AGONIST PEPTIDE COMPOUNDS AND USES THEREOF | Takeda Pharmaceutical Company Limited (JP) | 2023-02-08 | — | — | EP | claimed |
| EP-4126921-A2 | QD DOSING OF GIP RECEPTOR AGONIST PEPTIDE COMPOUNDS AND USES THEREOF | Takeda Pharmaceutical Company Limited (JP) | 2023-02-08 | — | — | EP | claimed |
| WO-2022256800-A2 | HUMAN SPERMINE OXIDASE CRYSTAL AND USES THEREOF | JANSSEN VACCINES & PREVENTION B.V. (NL) | 2022-12-08 | — | — | WO | claimed |
| CN-115335395-A | QD administration of GIP receptor agonist peptide compounds and uses thereof | 武田药品工业株式会社 | 2022-11-11 | — | — | CN | claimed |
| US-20220227830-A1 | QD DOSING OF GIP RECEPTOR AGONIST PEPTIDE COMPOUNDS AND USES THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2022-07-21 | — | — | US | claimed |
| WO-2022148418-A1 | PHARMACEUTICAL COMPOSITION CAPABLE OF BEING DELIVERED BY METERED DOSE INHALER | 江苏恒瑞医药股份有限公司 | 2022-07-14 | — | — | WO | claimed |
| WO-2022079639-A1 | GLP-1/GIP DUAL AGONISTS | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2022-04-21 | — | — | WO | claimed |
| US-20220041676-A1 | GIP AGONIST COMPOUNDS AND METHODS | ZEALAND PHARMA A/S (DK) | 2022-02-10 | — | — | US | claimed |